Surmodics' PROWL Registry data to unveil new clinical insights

Traders Union
All News
Market Voices
Surmodics to unveil registry data

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Mikhail Vnuchkov

27.10.2025

Surmodics' PROWL Registry data to unveil new clinical insights — @Surmodics: Surmodics to unveil registry data

Surmodics is set to unveil new data from its PROWL Registry at the VIVA25 conference.

This data will showcase the latest clinical research findings on the Pounce Thrombectomy System. Lead investigators will present their insights on November 3, 2025, at 3:15 pm in Las Vegas. The PROWL Registry data is anticipated to provide significant insights into thrombectomy advancements, which could have implications for future medical practices.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

The forthcoming PROWL Registry findings arrive as Surmodics continues to expand its footprint in thrombectomy innovation. Recent developments, such as advances in the Pounce LP Thrombectomy System designed for limb salvage in peripheral arterial disease, have highlighted the company's commitment to broadening therapeutic options. Earlier results demonstrating how the Pounce Venous Thrombectomy System restores critical vein flow have also underscored the potential impact on standard venous care.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

By Anastasiia Chabaniuk
23 hours ago

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Editors' Picks

Aiming for leadership: Payment giants prepare a new stablecoin

By Mikhail Vnuchkov
Yesterday

Aiming for leadership: Payment giants prepare a new stablecoin

Editors' Picks

Proof of Reserves: the new standard for cryptocurrency exchanges

By Pavlo Kot
04.07.2026

Proof of Reserves: the new standard for cryptocurrency exchanges

Editors' Picks

All Editors' Top Picks

Latest Surmodics News

Transradial approach achieves anterior tibial artery revascularization with Sublime Microcatheter, Surmodics reveals

By Parshwa Turakhiya
14.05.2026

Transradial approach achieves anterior tibial artery revascularization with Sublime Microcatheter, Surmodics reveals

Companies

Surmodics presents new Sublime Microcatheter and Pounce Thrombectomy systems at SIR26TOR

By Mikhail Vnuchkov
15.04.2026

Surmodics presents new Sublime Microcatheter and Pounce Thrombectomy systems at SIR26TOR

Companies

New Surmodics thrombectomy systems unveiled for vascular care at SIR26TOR

By Dmytro Kharkov
10.04.2026

New Surmodics thrombectomy systems unveiled for vascular care at SIR26TOR

Companies

All Surmodics News

Anastasiia Chabaniuk
23 hours ago

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Mikhail Vnuchkov
Yesterday

Aiming for leadership: Payment giants prepare a new stablecoin

Pavlo Kot
04.07.2026

Proof of Reserves: the new standard for cryptocurrency exchanges

Eugene Komchuk
03.07.2026

Three trends that could reshape the crypto market over the next decade

Oleg Tkachenko
02.07.2026

Trump financial disclosure: How the president's crypto income became a U.S. ethics issue

Hanna Syniavska
32 min ago

Gregory Raymond: Crédit Agricole strengthens CACEIS at core of institutional on-chain finance

Yulia Slavina
36 min ago

Manchester's spending power dropped 7 percent between 2021 and 2023, Kelvin MacKenzie notes

Igor Krasulya
1 hour ago

Oil prices trade above $70 amid U.S.–Iran tensions, Mohamed A. El-Erian notes

Ivan Andriyenko
2 hours ago

Michael Pettis: Lower birth rates linked to higher productivity growth

Anastasiia Chabaniuk
2 hours ago

John Redwood: HS2 head earns £600,000 salary amid overspending concerns

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Igor Krasulya
48 min ago

Oil prices rise after U.S. launches new Iran strikes

Oil prices rise after U.S. launches new Iran strikes

Ivan Andriyenko
17 hours ago

IEA sees first global gas demand drop since 2022

IEA sees first global gas demand drop since 2022

Parshwa Turakhiya
20 hours ago

Tether brings USDT back to Bitcoin after years away

Tether brings USDT back to Bitcoin after years away

Hanna Syniavska
21 hours ago

Nasdaq futures weaken as tech caution returns

Nasdaq futures weaken as tech caution returns

Ivan Andriyenko
22 hours ago

Oil climbs as Hormuz shipping risks remain in focus

Oil climbs as Hormuz shipping risks remain in focus

Top 5 companies for you

United States

Live News

Mykhailo Ihnatenko
Now

Bitcoin price holds above $62,000 as Middle East tensions rise and spot ETF inflows slow.

Anton Kharitonov
Now

Alphabet extends recovery as AI leadership and fusion investment strengthen outlook

Anton Kharitonov
Now

Microsoft extends recovery as AI investments remain in focus

Mykhailo Ihnatenko
Now

Moderna stock price outlook: Is the rally overextended?

Anton Kharitonov
Now

Apple approaches resistance as AI optimism supports recovery

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.